share_log

Barclays Upgrades Amdocs to Overweight, Raises Price Target to $115

Barclays Upgrades Amdocs to Overweight, Raises Price Target to $115

巴克莱将Amdocs上调至增持,将目标价上调至115美元
Benzinga ·  2023/05/16 04:55

Barclays analyst Tavy Rosner upgrades Amdocs (NASDAQ:DOX) from Equal-Weight to Overweight and raises the price target from $100 to $115.

巴克莱分析师塔维·罗斯纳将Amdocs(纳斯达克股票代码:DOX)从等重上调至增持,并将目标股价从100美元上调至115美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发